INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Crossmark Global Holdings, Inc.'s Holding History (CIK: 0001539204)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,603 Value ($000) $211 Avg Close Range
Q2 2024
Shares 4,652 Value ($000) $0 Avg Close Range
Q1 2024
Shares 6,172 Value ($000) $0 Avg Close Range
Q4 2023
Shares 8,199 Value ($000) $1 Avg Close Range
Q3 2023
Shares 8,199 Value ($000) $0 Avg Close Range
Q2 2023
Shares 7,666 Value ($000) $0 Avg Close Range
Q1 2023
Shares 7,656 Value ($000) $0 Avg Close Range
Q4 2022
Shares 7,662 Value ($000) $0 Avg Close Range
Q3 2022
Shares 6,977 Value ($000) $325 Avg Close Range
Q2 2022
Shares 5,950 Value ($000) $340 Avg Close Range